Kumari S

About

Highly motivated researcher with a proven track record in translational breast cancer research. My expertise encompasses molecular biology, signal pathways, metastatic processes, oncological targets and therapies, and drug discovery. I excel in designing experiments, executing projects, and managing independent research. Proficient in experimental design, executing projects promptly, and skilled in molecular biology, cell biology, and signal transduction. Experienced in leading independent projects, demonstrating exceptional writing and communication abilities. Adept at graduate and postgraduate level teaching, advocating for interdisciplinary approaches integrating cell biology, molecular biology, bioinformatics, and biochemical techniques. Excellent analytical and problem-solving abilities and a strong publication record. Like to expand my knowledge, embrace new concepts and technologies, and contribute to the field of cancer biology.

Employment

• Dr. B.R Ambedkar University, Srikakulam, Andhra Pradesh Faculty
  2025 - Present
• GITAM University Research Scientist (Visiting)
  2023 - Present
• Medical College of Wisconsin Post Doctoral Fellow
  2022 - 2023
• UGC-PFW (GITAM University) Post doctoral fellow
  2014 - 2019
• Andhra University Lecturer
  2004 - 2012

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (71)

• Mapping cellular heterogeneity and dynamic interactions in pancreatic cancer
  Journal of Controlled Release 2026 DOI: 10.1016/j.jconrel.2026.114757
  +Save
• Briefing on Nitric Oxide a Signal Molecule in Cancer Metastasis and Therapeutic Target
  Cell Biochemistry and Function 2026 DOI: 10.1002/cbf.70191
  +Save
• Cytokine epigenetics network for gastric cancer progression and chemoresistance
  Pharmacological Research 2026 DOI: 10.1016/j.phrs.2026.108136
  +Save
• Developments of AI based early detection and diagnosis method in pancreatic cancer
  Artificial Intelligence in Gastrointestinal Cancers 2026 DOI: 10.1016/b978-0-443-44121-9.00001-9
  +Save
• Pancreatic ductal adenocarcinoma: integrating molecular insights for targeted interventions
  Signal Transduction and Targeted Therapy 2026 DOI: 10.1038/s41392-026-02705-5
  +Save
• DIFERULOYLMETHANE IDENTIFIED AGAINST CYSTEINE PROTEASES AND TMPRSS2 USING IN SILICO APPROACH
  International Journal of Chemistry Research 2025 DOI: 10.22159/ijcr.2025v9i3.270
  +Save
• MMPs (-2 and -9)-mediated drug resistance and their reversal in gynecological cancer
  Pathophysiological Aspects of Proteases in Cancer 2025 DOI: 10.1016/b978-0-443-30098-1.00024-0
  +Save
• Immunotherapy in colorectal cancer: Understanding the PD-1 and CTLA-4 targeted therapies for MSI-H/dMMR tumors
  Immune Therapy for Pancreatic and Colon Cancers 2025 DOI: 10.1016/b978-0-443-24742-2.00013-7
  +Save
• Challenges in immunotherapy for PDAC: Overcoming immune resistance and enhancing treatment strategies
  Immune Therapy for Pancreatic and Colon Cancers 2025 DOI: 10.1016/b978-0-443-24742-2.00004-6
  +Save
• Polysaccharides as therapeutic vehicles in pancreatic cancer
  Drug Discovery Today 2025 DOI: 10.1016/j.drudis.2025.104320
  +Save